Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape
Project Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
Pharma R&D Annual Review Supplement: New Active Substances
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
Mastering Scope 3 Emissions In Clinical Trials
Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.
Leveraging Mobile Vision Clinics For Clinical Trial Exams
Are you considering new options to improve your patient experience and expand your clinical trial's reach? 20/20 Onsite's mobile vision clinics provide a full optometry suite for all types of clinical trials.

Bringing Intelligence Into The Flow Of Clinical Trials
4/16/2026

AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.
Real-World Data Has Real Impact On Clinical Research
9/18/2025

The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
Human Abuse Potential: Subjective Ratings
5/5/2026

Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity
3/28/2025

The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.
How Community-Based Research Models Expand Access
9/9/2025

As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

Central Nervous System Drug Development

CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
Turnkey Solutions For Your Renal And Hepatic Impairment Studies

With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
Safe-To-Site Initiative

By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
Metabolic Disorders

Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
User Acceptance Testing (UAT): Keeping Trials On Track

Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.